ACTION IN DIABETES VASCULAR DISEASE: PRETERAX AND DIAMICRON MR CONTROLLED EVALUATION
H Y P E R T E N S I O N I N T H E V E R Y E L D E R L Y T R I A L
SH Tf
I
BEAUT UL
f
I
2008
2010
2008
2007
P R E A M I
P
erindopril and
R
emodelling in
E
lderly
with
A
cute
M
yocardial
I
nfarction
2005
2005
2003
2001
Major Advances
in Cardiology
S3
PREXUM® PLUS Tablets. Perindopril 4 mg and Indapamide 1,25 mg. Reg. No. 38/7.1.3/0028.
S3
COVERSYL® PLUS Tablets. Perindopril 4 mg and Indapamide 1.25 mg.
Reg. No.: 33/7.1.3/0363.
S3
PREXUM® 4 mg Tablets. Perindopril 4 mg. Reg. No. 36/7.1.3/0020.
S3
PREXUM® 10 mg Tablets. Perindopril 10 mg. Reg. No. A39/7.1.3/0233.
S3
COVERSYL® 4 mgTablets. Perindopril 4 mg. Reg. No.: X/7.1.3/314.
S3
COVERSYL® 10 mgTablets. Perindopril 10 mg. Reg. No. A39/7.1.3/0236.
S3
CORALAN® 7,5 mgTablets.
Ivabradine 7,5 mg. Reg. No. A39/7.1.4/4011. For full prescribing information, refer to package insert approved by medicines regulatory authority.
NAME AND BUSINESS ADDRESS OF THE HOLDER OF THE CERTIFICATE:
SERVIER LABORATORIES SOUTH AFRICA (Pty) Ltd. Reg. No. 72/14307/07. Building Number 4,
Country Club Estate, 21 Woodlands Drive, Woodmead 2191. PO Box 930, Rivonia 2128, Republic of South Africa. Tel: +27 (0) 861 700 900. Fax: +27(0)11 525 3401. 144592
PREXUM
®
COVERSYL
®
ONCE DAILY
Perindopril 4 mg/Indapamide 1.25 mg
PLUS
PREXUM
®
COVERSYL
®
ONCE DAILY
P e r i n d o p r i l
4 - 10 mg
